Cargando…

Association Between Early Antibiotic Exposure and Bronchopulmonary Dysplasia or Death

OBJECTIVE: To characterize the independent association between antibiotic exposure in the first week of life and the risk of bronchopulmonary dysplasia (BPD) or death among very preterm infants without culture-confirmed sepsis. METHODS: Retrospective cohort study using the Optum Neonatal Database. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flannery, Dustin D, Dysart, Kevin, Cook, Alison, Greenspan, Jay, Aghai, Zubair H, Jensen, Erik A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195849/ https://www.ncbi.nlm.nih.gov/pubmed/29895965 http://dx.doi.org/10.1038/s41372-018-0146-3

Ejemplares similares

Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Jensen, Erik A., et al.
Publicado: (2023)

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
por: Jensen, Erik A., et al.
Publicado: (2019)

Duration of Noninvasive Respiratory Support and Risk for Bronchopulmonary Dysplasia or Death
por: Gentle, Samuel J, et al.
Publicado: (2022)

Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6
por: Chaubey, Sushma, et al.
Publicado: (2018)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
por: Nardiello, Claudio, et al.
Publicado: (2017)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Effect of antibiotic-induced intestinal dysbacteriosis on bronchopulmonary dysplasia and related mechanisms
por: Ran, Xiao, et al.
Publicado: (2021)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Placental Neutrophil Infiltration Associated with Tobacco Exposure but Not Development of Bronchopulmonary Dysplasia
por: Box, David M., et al.
Publicado: (2022)

Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia
por: Hysinger, Erik B., et al.
Publicado: (2023)

Bronchopulmonary Dysplasia Early Changes Leading to Long-Term Consequences
por: Hilgendorff, Anne, et al.
Publicado: (2015)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia
por: Sun, Yuanyuan, et al.
Publicado: (2019)

Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
por: Kindt, Alida S. D., et al.
Publicado: (2022)

Effectiveness and safety of repeat dexamethasone for bronchopulmonary dysplasia
por: Cuna, Alain, et al.
Publicado: (2021)

Predictors of Bronchopulmonary Dysplasia or Death in Premature Infants with a Patent Ductus Arteriosus
por: Chock, Valerie Y., et al.
Publicado: (2013)

Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
por: Giusto, Kiersten, et al.
Publicado: (2021)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7kcj33tk1d0om574fnrhcqkfr